News
In June this year, Paul Henderson received test results showing elevated PSA (prostate-specific antigen) levels. In this ...
In June this year, Paul Henderson received test results showing elevated PSA levels. In this weekly diary, he will be sharing ...
Nuclear imaging is entering a period of notable change. Positron emission tomography (PET) scans are gaining traction in ...
AI tool DirectORGANS may streamline prostate cancer radiotherapy planning by safely autocontouring organs—but manual review ...
Stockhead on MSN12d
Dr Boreham’s Crucible: Clarity is a clear and strong contender in the prostate cancer treatment race
"More like AC/DC than the Wiggles", Clarity Pharmaceuticals is looking to make it big in the US with Australian tech.
It’s been more than 50 years since I had to stay overnight in a hospital as a 14-year-old with appendicitis … until now. But ...
According to GlobalData, PET agents are projected to grow at a CAGR of 4.6 per cent in market value and 4.7 per cent in ...
Stockhead on MSN8d
Dr Boreham’s Crucible: In the shadow of giants, but can this biotech become a tumour-tackling titan?
Radiopharm Theranostics (ASX:RAD) is lining up multiple shots at oncology goals. Maybe one, maybe more, will hit the back of the net.
Tech Irish medtech ProVerum raises €68m to launch novel prostate treatment. Tech; Tech audio; Live News; Medtech; ProVerum; ...
Q2 2025 Earnings Call Transcript August 11, 2025 Operator: Good day, and welcome to RadNet, Inc. Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note this event ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback